Michael E. Porter, Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 5,000 shares at $7.20 ($36K) on 2016-03-17, disclosed to the SEC on 2016-03-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MACK | BUY | 2016-03-04 | $159K | — | Filing → |
| MACK | BUY | 2016-03-02 | $122K | — | Filing → |
| MACK | BUY | 2015-08-25 | $49K | — | Filing → |